Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Jim Cramer is weighing out the risks of weight loss drugs
07:36pm, Wednesday, 11'th Oct 2023
'Mad Money' host Jim Cramer takes a deep dive into the impact of obesity drugs on various sectors.
ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes
12:46pm, Monday, 09'th Oct 2023
ResMed's (RMD) respiratory care business continues to drive growth and the adoption of bilevel and other non-invasive ventilator solutions worldwide.
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
04:05pm, Thursday, 05'th Oct 2023
SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2024 on Thursday, O
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
10:32am, Tuesday, 03'rd Oct 2023
Investors continue to be optimistic about ResMed (RMD) due to the core business' performance and sustained growth in the SaaS business.
Will ResMed Stock Rebound To Its Pre-Inflation Shock Highs Of $300?
09:00am, Monday, 02'nd Oct 2023
This compares with the Sharpe of 1.3 for the Trefis Reinforced Value portfolio.
Here are 11 stocks Jim Cramer is watching, including Buffett's Berkshire and restaurant stocks
10:17am, Friday, 29'th Sep 2023
Here are some of the tickers on my radar for Friday, Sept. 29, taken directly from my reporter's notebook.
ResMed (RMD) Stock Jumps 3.8%: Will It Continue to Soar?
07:31am, Thursday, 28'th Sep 2023
ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.
08:38am, Tuesday, 26'th Sep 2023
Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as ever.
ResMed - Trading Opportunity Now
03:27pm, Tuesday, 12'th Sep 2023
ResMed is the global leader in the sleep apnea market. Sales growth accelerated during COVID and again recently as a result of a product recall from its major competitor. Despite a strong last quarter
ResMed Announces Participation in Upcoming Conferences
04:05pm, Tuesday, 05'th Sep 2023
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences.
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy
06:21am, Friday, 01'st Sep 2023
Some investors in ResMed, which makes machines for people with sleep apnea, think that effective new weight-loss drugs could shrink its addressable market. On ResMed's latest earnings call, CEO Mick F
Late-Summer Steals: 7 Stocks to Buy Before Fall
09:48pm, Monday, 28'th Aug 2023
With summer coming to an end, investors may want to target certain compelling stocks to buy now. Basically, the theory is the reverse of the adage, sell in May and go away.
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
11:17am, Tuesday, 22'nd Aug 2023
Investors continue to be optimistic about ResMed (RMD), backed by the continued demand for digital health solutions.
Buy the Drop: 3 Stocks to Snag After This Month's 20% Tumble
04:26pm, Monday, 21'st Aug 2023
August has been a great month for investors looking for bargain stocks to buy on the dip. The S&P 500, Dow Jones Industrial Average, and the Nasdaq 100 were down 2,1%, 2.0%, and 2.4%, respectively, fo
5 Blue-Chip Stocks AI Thinks Will Double Your Money by 2027
12:42pm, Wednesday, 16'th Aug 2023
In June, I introduced five stocks that AI predicted could double a portfolio in a year. Here's how they've done in the first month.
